Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eldecalcitol versus calcitriol in postmenopausal women with low bone mineral density or mild osteoporosis
ChiCTR2300070456Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of eldecalcitol and calcitriol in osteoporosis and osteopenia (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Percent change in lumbar spine bone mineral density at 12 months. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
eldecalcitolcalcitriol
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on ChiCTR2300070456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070456.